Know Labs, Inc. Common Stock (KNW)

Competitors to Know Labs, Inc. Common Stock (KNW)

Abbott Laboratories 

Abbott, with its FreeStyle Libre product line, has a strong foothold in the glucose monitoring space, offering both invasive and non-invasive options. Know Labs competes through its promise of more user-friendly, non-invasive solutions. As a larger organization with extensive resources and a diversified product range, Abbott can leverage its existing distribution networks and customer relationships to maintain a competitive edge.

Dexcom, Inc. 

Dexcom specializes in continuous glucose monitoring systems that provide real-time glucose readings for diabetes management. Know Labs, which focuses on non-invasive glucose monitoring technology, competes with Dexcom's established market presence and advanced sensor technology. While Know Labs aims to provide an innovative, non-invasive approach, Dexcom has built a robust reputation and a loyal customer base in the diabetes management sector.

Glooko, Inc.

Glooko focuses on providing a digital health platform that integrates data from various diabetes management devices, including glucose meters and insulin pumps. Know Labs competes by offering its own device aimed at simplifying glucose monitoring. However, Glooko’s comprehensive data integration and analytics capabilities provide an additional layer of value for users, giving it a competitive edge in terms of data management and patient engagement.

Medtronic plc 

Medtronic is a major player in diabetes care, providing a comprehensive suite of devices including insulin pumps and glucose monitoring systems. Know Labs offers innovative non-invasive technology aimed at similar patient demographics. However, Medtronic's established brand and integration of devices into broader diabetes management solutions create a competitive advantage that positions it strongly in the market.

Senseonics Holdings, Inc. 

Senseonics develops long-term implantable glucose monitoring systems, providing a different approach to glucose management compared to Know Labs' non-invasive technology. While both companies target users with diabetes, Senseonics adheres to a strategy focused on longer-term glucose monitoring through implants, which may attract patients looking for consistent, long-lasting solutions, thereby possibly placing them ahead in certain segments.